Tiziana Life Sciences is trading 6.36% down at $1.07, with no clear company-specific announcement emerging on August 18, 2026.

  • Latest listed company disclosures remain CEO share purchases announced August 4 and August 6.
  • Broader markets are weaker, including the Nasdaq Composite, down 1.41%.
  • The decline appears consistent with risk-off sentiment, though a direct catalyst has not been identified.